SELLAS Life Sciences Group, Inc. (SLS) (CIK 0001390478) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001104659-25-114977
- Form
- CORRESP
- Filer
- SELLAS Life Sciences Group, Inc. (SLS) (CIK 0001390478)
- CIK
- 0001390478
- Ticker
- SLS
- Filed
- 2025-11-21
- SIC industry
- 2834
- HQ
- New York, NY
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1390478/000110465925114977/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗